These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 19474472

  • 1. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.
    Huang KH, Loutfy MR, Boulet S, Toma E, Tsoukas CM, Bernard NF.
    Antivir Ther; 2009; 14(3):381-92. PubMed ID: 19474472
    [Abstract] [Full Text] [Related]

  • 2. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF, Price P, French MA.
    HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
    [Abstract] [Full Text] [Related]

  • 3. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
    Kolber MA.
    AIDS; 2008 Oct 01; 22(15):1937-41. PubMed ID: 18784457
    [Abstract] [Full Text] [Related]

  • 4. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
    Nemes E, Lugli E, Nasi M, Ferraresi R, Pinti M, Bugarini R, Borghi V, Prati F, Esposito R, Cossarizza A, Mussini C.
    AIDS; 2006 Oct 24; 20(16):2021-32. PubMed ID: 17053348
    [Abstract] [Full Text] [Related]

  • 5. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
    Negredo E, Massanella M, Puig J, Pérez-Alvarez N, Gallego-Escuredo JM, Villarroya J, Villarroya F, Moltó J, Santos JR, Clotet B, Blanco J.
    Clin Infect Dis; 2010 May 01; 50(9):1300-8. PubMed ID: 20367229
    [Abstract] [Full Text] [Related]

  • 6. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
    Beran O, Holub M, Spála J, Kalanin J, Stanková M.
    Acta Virol; 2003 May 01; 47(2):121-4. PubMed ID: 14524479
    [Abstract] [Full Text] [Related]

  • 7. Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment.
    Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Frøland SS, Taskén K.
    AIDS; 2006 Apr 04; 20(6):813-20. PubMed ID: 16549964
    [Abstract] [Full Text] [Related]

  • 8. Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption.
    Huang KH, Loutfy MR, Tsoukas CM, Bernard NF.
    BMC Infect Dis; 2008 May 02; 8():59. PubMed ID: 18454861
    [Abstract] [Full Text] [Related]

  • 9. Factors predicting the time for CD4 T-cell count to return to nadir in the course of CD4-guided therapy interruption in chronic HIV infection.
    Boschi A, Tinelli C, Ortolani P, Arlotti M.
    HIV Med; 2008 Jan 02; 9(1):19-26. PubMed ID: 18199169
    [Abstract] [Full Text] [Related]

  • 10. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, Landay A, Haubrich R.
    J Infect Dis; 2006 Jul 01; 194(1):29-37. PubMed ID: 16741879
    [Abstract] [Full Text] [Related]

  • 11. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C, Mocroft A, Kirk O, Vella S, Blaxhult A, Clumeck N, Fisher M, Katlama C, Phillips AN, Lundgren JD, EuroSIDA study group.
    HIV Med; 2007 Mar 01; 8(2):96-104. PubMed ID: 17352766
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.
    Lécuroux C, Girault I, Boutboul F, Urrutia A, Goujard C, Meyer L, Lambotte O, Chaix ML, Martinez V, Autran B, Sinet M, Venet A, ANRS PRIMO Cohort, ANRS HIC Study Group, ANRS ALT Cohort, ANRS HIC Study Group.
    AIDS; 2009 Aug 24; 23(13):1649-58. PubMed ID: 19617814
    [Abstract] [Full Text] [Related]

  • 15. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ, Su Z, Havlir DV, Robertson KR, Coombs RW, Cain P, Peterson T, Krambrink A, Jahed N, McMahon D, Margolis DM, AIDS Clinical Trials Group 5170 Study Team.
    J Infect Dis; 2007 May 15; 195(10):1426-36. PubMed ID: 17436222
    [Abstract] [Full Text] [Related]

  • 16. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
    Almeida M, Cordero M, Almeida J, Orfao A.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):22-33. PubMed ID: 17051525
    [Abstract] [Full Text] [Related]

  • 17. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy.
    Siddique MA, Hartman KE, Dragileva E, Dondero M, Gebretsadik T, Shintani A, Peiperl L, Valentine F, Kalams SA.
    J Infect Dis; 2006 Sep 01; 194(5):661-5. PubMed ID: 16897665
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Altered T cell differentiation associated with loss of CD27 and CD28 in HIV infected Indian individuals.
    Mojumdar K, Vajpayee M, Chauhan NK, Singh A, Singh R, Kurapati S.
    Cytometry B Clin Cytom; 2012 Jan 01; 82(1):43-53. PubMed ID: 21695776
    [Abstract] [Full Text] [Related]

  • 20. Regulatory T cells generated during cytomegalovirus in vitro stimulation of mononuclear cells from HIV-infected individuals on HAART correlate with decreased lymphocyte proliferation.
    Jesser RD, Li S, Weinberg A.
    Virology; 2006 Sep 01; 352(2):408-17. PubMed ID: 16782163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.